This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Sun Y, et al. A novel myh9-ret fusion occurrence and EGFR T790M loss as an acquired resistance mechanism to osimertinib in a patient with lung adenocarcinoma: A case report. OncoTargets and Therapy 13: 11177-11181, 2 Nov 2020. Available from: URL: http://doi.org/10.2147/OTT.S267524